CINs of the cytoplasm: dissecting dsRNA signaling in chromosomal instability. [PDF]
Skolariki A, Jady-Clark RL, Parkes EE.
europepmc +1 more source
Adenosine-to-inosine RNA editing in cancer: molecular mechanisms and downstream targets. [PDF]
Cheng H, Yu J, Wong CC.
europepmc +1 more source
ADAR Therapeutics as a New Tool for Personalized Medicine. [PDF]
Bertoli M, La Via L, Barbon A.
europepmc +1 more source
Novel lncRNA <i>UGGT1-AS1</i> Regulates <i>UGGT1</i> Expression in Breast Cancer Cell Line. [PDF]
Samorowska K+2 more
europepmc +1 more source
Alternative splicing of transposable elements in human breast cancer. [PDF]
Nesta A+4 more
europepmc +1 more source
A rare presentation of dyschromatosis symmetrica hereditaria in a Canadian context: A case report. [PDF]
Czyz S, Jafarian F, Holfeld K.
europepmc +1 more source
Enhancing RNA editing efficiency and specificity with engineered ADAR2 guide RNAs. [PDF]
Ai X+8 more
europepmc +1 more source
BALF editome profiling reveals A-to-I RNA editing associated with severity and complications of <i>Mycoplasma pneumoniae</i> pneumonia in children. [PDF]
Jin Y-Y+5 more
europepmc +1 more source
A-to-I RNA edited POLA2 attains carcinogenesis in prostatic cancer by impeding immune infiltration and upregulating BTBD7. [PDF]
Lin S, Huang H, Li Y, Lu Y, Ye T.
europepmc +1 more source
ADARp110 promotes hepatocellular carcinoma progression via stabilization of CD24 mRNA. [PDF]
Sun L+15 more
europepmc +1 more source